| Mr Jeffrey R Bresnahan, MPT, DPT | |
|
12509 E. Mission Ave., Ste. 202, Spokane, WA 99216 | |
| (509) 444-5678 | |
| Not Available |
| Full Name | Mr Jeffrey R Bresnahan |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 12509 E. Mission Ave., Spokane, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023105327 | NPI | - | NPPES |
| 8422628 | Medicaid | WA | |
| P00704709 | Other | WA | RR MEDICARE |
| P007047019 | Other | WA | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT 00009538 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jeffrey R Bresnahan, MPT, DPT 16083 Sw Upper Boones Ferry Rd, Suite 300, Tigard, OR 97224-7736 Ph: (800) 219-8835 | Mr Jeffrey R Bresnahan, MPT, DPT 12509 E. Mission Ave., Ste. 202, Spokane, WA 99216 Ph: (509) 444-5678 |
News Archive
GlaxoSmithKline (GSK) and ChemoCentryx, Inc. today announced that GSK has exercised its option to obtain an exclusive license for further development and worldwide commercialization of Traficet-EN(TM) (CCX282-B), a specific CCR9 antagonist with the potential to offer a new approach for the treatment of inflammatory bowel diseases, including Crohn's disease.
However, the nucleocapsid (N) protein is also extremely abundant and, therefore, a useful target for both vaccine and diagnostic test development. A new study published on the preprint server bioRxiv in August 2020 reveals the structure of this protein, a valuable step in using it for these purposes.
Mayo Clinic researchers, as part of a nine-site study, helped discover the best of three currently-used treatments for convergence insufficiency in children. Convergence refers to the natural ability of the eyes to focus and align while viewing objects up close.
New data shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
King Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the New Drug Application (NDA) for CorVue™ (binodenoson) for injection.
› Verified 7 days ago
Brian Kinder, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 711 S Cowley St, Spokane, WA 99202 Phone: 509-473-9920 | |
Meghan K Fitzgerald, BS MPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1403 S Grand Blvd, Suite #102-s, Spokane, WA 99203 Phone: 509-624-4200 Fax: 509-624-2817 | |
Shirley Joanne Carlson, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2118 W Garland Ave, Spokane, WA 99205 Phone: 509-326-1651 Fax: 509-326-1658 | |
Michael Dean Swanson, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 785 E Holland Ave, Spokane, WA 99218 Phone: 509-466-6393 Fax: 509-466-5163 | |
Christy J Frazier, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1111 E Westview Ct, Suite A, Spokane, WA 99218 Phone: 509-465-1749 Fax: 509-465-1748 | |
Lianna Jeanne Philbin, PHYSICAL THERAPIST Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1812 N Wall St, Spokane, WA 99205 Phone: 509-328-6030 | |
Dr. Alec Webbenhurst, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1224 E Westview Ct, Spokane, WA 99218 Phone: 509-465-8800 |